Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more here.

Contact Us
Contact Us

Video Library

25 Sep 2023
Master Investor Sector Focus: Healthcare
20 Sep 2023
hVIVO Canary Wharf Facilities - Adam French
13 Sep 2023
hVIVO PLC - Interim Results Presentation
12 Sep 2023
Q&A with hVIVO’s Mo Khan
12 Sep 2023
hVIVO has "the perfect opportunity" after strong first half
29 Aug 2023
Q&A with hVIVO’s CEO, Mo Khan
29 Aug 2023
hVIVO announces move to "good facility at a very good price"
31 Jul 2023
Developing an Influenza B Human Challenge Model
26 Jul 2023
hVIVO plc – Trading update H1 2023
26 Jul 2023
hVIVO’s Mo Khan: “We have now got 100% contracted work this year to hit our revenue targets”
26 Jul 2023
hVIVO CEO reports on "very strong" H1 2023
25 Jul 2023
hVIVO’s Mo Khan: “the industry is really waking up to the value of human challenge models"
25 Jul 2023
hVIVO signs second bespoke human challenge model contract in as many months
10 Jul 2023
hVIVO targeting the nasty virus no one has heard of
29 Jun 2023
hVIVO to Develop hMPV Human Challenge Model
28 Jun 2023
hVIVO to develop first commercial hMPV human challenge model
15 May 2023
The people who get paid to get sick
15 May 2023
Topra Webinar - Human Challenge Trials: Supporting the development of ‘next generation’ COVID-19 Vaccines
25 Apr 2023
hVIVO PLC - Full Year Results
25 Apr 2023
hVIVO reveals audited results for "transformational" 2022
14 Apr 2023
hVIVO at World Vaccine Congress Washington 2023
06 Feb 2023
hVIVO Asian growth strategy bearing fruit with second 2023 contract win
25 Jan 2023
hVIVO PLC - Investor Presentation
15 Jan 2023
hVIVO announces "record results" for 2022
04 Jan 2023
hVIVO contract the fruit of increasing Asian focus
03 Jan 2023
Year in Review 2022 - hVIVO Group
10 Dec 2022
Vox Markets Fund Manager Series: Patrick Armstrong, CIO at Plurimi Wealth
10 Nov 2022
hVIVO hails growing contract values after winning £13.6mln RSV challenge trial deal
17 Oct 2022
Open Orphan chief financial officer confident of "sustainable profitable growth"
08 Sep 2022
OPEN ORPHAN PLC - Interim results - Investor presentation
08 Sep 2022
Open Orphan's CEO talks through name change and a first half 'full of highlights'
05 Aug 2022
£6.2m Influenza human challenge study contract - BRR Media
04 Aug 2022
Open Orphan subsidiary hVIVO wins £6.2m Influenza human challenge study contract with US customer
01 Jul 2022
hVIVO developing World's First Omicron Human Challenge Model
01 Jul 2022
Open Orphan and Vaxart are preparing a world-first human challenge model for omicron oral vaccine
14 Jun 2022
hVIVO’s £7.2m RSV Human Challenge Model Contract
07 Jun 2022
Open Orphan’s Yamin Khan talks through its ‘excellent’ results
01 Jun 2022
Open Orphan racks up another ‘first’ with £14.7mln full-service flu contract
19 May 2022
Chief Scientific Officer on Influenza Challenge Study contract Win
15 Jun 2022
LSX World Congress Showcase Open Orphan
09 Mar 2022
London South East were delighted to host Open Orphan, Orosur, Petro Matad, Aura Minerals last night
08 Mar 2022
Open Orphan sticks to 2021 earnings guidance as it announces an expansion of its facilities
08 Mar 2022
Volunteer Recruitment & Laboratory Facilities Expansion – Robin Rogiers & BRR Media
24 Feb 2022
CEO Appointment at Open Orphan
24 Feb 2022
Open Orphan announce Yamin ‘Mo’ Khan as new CEO
17 Feb 2022
hVIVO hail data on phase 2a study published in New England Journal of Medicine
14 Feb 2022
Open Orphan subsidiary hVIVO launch of STRiVE to ‘find out what people are actually suffering from’
14 Feb 2022
Adrian Wildfire on hVIVO STRiVE Project
02 Feb 2022
Open Orphan’s Cathal Friel presents results from world’s first COVID-19 characterisation study
02 Feb 2022
Open Orphan present ‘invaluable’ key findings of world’s first COVID-19 characterisation study
02 Feb 2022
CSO Andrew Catchpole on the world’s first COVID-19 Characterisation Study
24 Jan 2022
Executive Chairman Cathal Friel on The world’s first COVID-19 Characterisation Study
24 Jan 2022
Adrian Wildfire hVIVO Malaria Challenge Agent – BRR Media
20 Jan 2022
BRR Interview Cathal Friel on Malaria Human challenge agent
20 Jan 2022
Open Orphan’s Cathal Friel on the ‘large opportunity’ for hVIVO subsidiary malaria study
20 Jan 2022
Open Orphan’s hVIVO subsidiary begin study for human malaria infection challenge study
21 Dec 2021
Open Orphan hail £5m contract for new flu jab challenge study
24 Aug 2021
Cathal Friel and BRR Media Discuss £8.1m Asthma Human Challenge Study Contract Win
20 Jul 2021
Open Orphan announce ‘substantial contract wins’ with an existing client and UK government
07 Jun 2021
FluCamp Hotel Quarantine Facility – Bedroom Tour
09 Apr 2021
Open Orphan: Global Leader in Human Challenge Vaccine Development | Executive Chairman Cathal Friel
17 Feb 2021
Open Orphan to become ‘$1bln firm in very near future’ after COVID-19 study receives ethics approval
16 Dec 2020
hVIVO secure MHRA approval to start Codagenix COVID-19 Phase I Vaccine Trial
16 Dec 2020
Shares Investor Evening with Cathal Friel December 2020
15 Dec 2020
Codagenix Covid vaccine phase I study approval interview on Sky News with Cathal Friel
07 Dec 2020
Open Orphan 2020 Year in Review
20 Nov 2020
COVID-19: UK scientists to infect volunteers with coronavirus in world first vaccine trial
20 Oct 2020
Young people to be deliberately exposed to Covid-19 to speed up vaccine development
20 Oct 2020
Market Coverage: Tuesday October 20 Yahoo Finance
06 Oct 2020
Shares Magazine Investor Evening October 2020
06 Oct 2020
Open Orphan Dual Business Firing on All Four Cylinders
01 Oct 2020
Open Orphan Interim Results Interview with BRR Media
10 Aug 2020
Interview with Proactive Investors following £4M contract with Top 3 Global Pharma company
17 Jun 2020
Open Orphan pushes ahead with hVIVO COVID Clear, the ‘most accurate’ antibody test
08 Jun 2020
Coronavirus: I took a COVID-19 antibody test to see if I’d had coronavirus without realising it
05 Jun 2020
Shares Magazine Open Orphan (ORPH) Presentation – Cathal Friel, Executive Chairman
06 Nov 2015
hVIVO – Introduction to our Quarantine & Medical Facilities
26 May 2015
BBC – The truth about your medicine cabinet
15 Sep 2014
hVIVO (formerly, and at the time of filming, Retroscreen) on BBC1 The One Show September 2014
11 May 2015
FluCamp – what it is like to participate in a clinical trial

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.

Contact hVIVO
chevron-downcross-circle